Synapse - Find an Expert

335 Results

A novel WWTR1::AFF2 fusion in an intra-abdominal soft tissue sarcoma with associated endometriosis

Journal Article

Dashti, N. K.; Dermawan, J. K.; Schoolmeester, J. K.; Halling, K. C.; Antonescu, C. R.
Genes Chromosomes and Cancer (2022)

Fulltext@MSK | Save

EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: A multicentre, open-label, phase 2 study

Journal Article

Zauderer, M. G.; Szlosarek, P. W.; Le Moulec, S.; Popat, S.; Taylor, P.; Planchard, D.; Scherpereel, A.; Koczywas, M.; Forster, M.; Cameron, R. B.; more...
Lancet Oncology (2022)

Fulltext@MSK | Save

A phase I study investigating AZD8186, a potent and selective inhibitor of PI3Kβ/δ, in patients with advanced solid tumors

Journal Article

Choudhury, A. D.; Higano, C. S.; de Bono, J. S.; Cook, N.; Rathkopf, D. E.; Wisinski, K. B.; Martin-Liberal, J.; Linch, M.; Heath, E. I.; Baird, R. D.; more...
Clinical Cancer Research (2022)

Fulltext@MSK | Save

Ibrutinib associated with rituximab-platinum salt-based immunochemotherapy in B-cell lymphomas: Results of a phase 1b-II study of the LYSA group

Journal Article

Bonnet, C.; Dupuis, J.; Tilly, H.; Lamy, T.; Fruchart, C.; le Gouill, S.; Thieblemont, C.; Morschhauser, F.; Casasnovas, O.; Bouabdallah, K.; more...
Cancers (2022)

Fulltext@MSK | Save

Abemaciclib in combination with endocrine therapy for patients with hormone receptor-positive, HER2-negative metastatic breast cancer: A phase 1b study

Journal Article

Tolaney, S. M.; Beeram, M.; Beck, J. T.; Conlin, A.; Dees, E. C.; Puhalla, S. L.; Rexer, B. N.; Burris, H. A. 3rd; Jhaveri, K.; Helsten, T.; more...
Frontiers in Oncology (2022)

Fulltext@MSK | Save

Regionalization of critical care in the United States: Current state and proposed framework from the Academic Leaders in Critical Care Medicine Task Force of the Society of Critical Care Medicine

Review

Leung, S.; Pastores, S. M.; Oropello, J. M.; Lilly, C. M.; Galvagno, S. M.; Badjatia, N.; Jacobi, J.; Herr, D. L.; Oliveira, J. D.; for the Academic Leaders in Critical Care Medicine Task Force of the Society of Critical Care Medicine
Critical Care Medicine (2022)

Fulltext@MSK | Save

Durable response to brentuximab vedotin plus cyclophosphamide, doxorubicin, and prednisone (BV-CHP) in a patient with CD30-positive PTCL arising as a post-transplant lymphoproliferative disorder (PTLD)

Journal Article

Hong, J.; Johnson, W. T.; Kartan, S.; Gonsalves, A. S.; Fenkel, J. M.; Gong, J. Z.; Porcu, P.
Current Oncology (2021)

Fulltext@MSK | Save

Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): A multicentre, open-label, phase 2a, multiple basket study

Journal Article

Javle, M.; Borad, M. J.; Azad, N. S.; Kurzrock, R.; Abou-Alfa, G. K.; George, B.; Hainsworth, J.; Meric-Bernstam, F.; Swanton, C.; Sweeney, C. J.; more...
Lancet Oncology (2021)

Fulltext@MSK | Save

Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): A multicentre, open-label, randomised, phase 3 trial